Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Health

China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial

South China Morning Post

HealthSouth China Morning Post·Aug 27, 2026·1 min read

China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial

Chinese biopharmaceutical firm Akeso announced on Wednesday that its immunotherapy drug had outperformed AstraZeneca’s Imfinzi in a head-to-head phase-three trial for biliary tract cancer. The result represents another breakthrough for…

View original source — South China Morning Post ↗

ShareShare on X Share on Facebook

Related stories

Family forced to leave NZ with huge bill for C-section raises $30k in days

HealthAug 27, 2026 · 1 min

Family forced to leave NZ with huge bill for C-section raises $30k in days

AI helps perform brain surgery on British man in world first

HealthAug 27, 2026 · 1 min

AI helps perform brain surgery on British man in world first

How low-dose computed tomography and AI are changing lung cancer screening

HealthAug 27, 2026 · 1 min

How low-dose computed tomography and AI are changing lung cancer screening

HealthAug 27, 2026 · 1 min

Lagos reviews Somolu hospital operations amid space constraints